Methyl (2S)-2-methylbutanoate
Common Name: |
Methyl (2S)-2-methylbutanoate |
IUPAC Name: |
methyl (2S)-2-methylbutanoate |
Molecular Formula: |
C6H10O |
SMILES: |
CCC(C)C(=O)OC |
Inchi: |
1S/C6H12O2/c1-4-5(2)6(7)8-3/h5H,4H2,1-3H3/t5-/m0/s1 |
Inchi Key: |
OCWLYWIFNDCWRZ-YFKPBYRVSA-N |
Cas No: |
10307-60-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
98.14 |
Mass (g/mol) |
116.084 |
Molar Refractivity |
30.68 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
3 |
Rings |
|
TPSA |
17.07 |
Hetero Atoms |
2 |
Heavy Atoms |
7 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
112.6 |
Vapor Pressure (mmHg@25.00 °C) |
21.591 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.50 |
LogP |
1.206 |
iLOGP |
1.61 |
XLOGP3 |
1.13 |
WLOGP |
1.54 |
MLOGP |
1.28 |
ESOL Log S |
-0.96 |
ESOL Solubility (mg/ml) |
10.7 |
ESOL Solubility (mol/l) |
0.109 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.08 |
Ali Solubility (mg/ml) |
8.12 |
Ali Solubility (mol/l) |
0.08 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.03 |
Silicos-IT Solubility (mg/ml) |
9.1 |
Silicos-IT Solubility (mol/l) |
0.09 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.10 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.336 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.938 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |